GlassScriptPhysician profile
Terral C Goode
NPI 1396902870
$7,795.19
in general payments reported to CMS, 2019-2025
5 companies · $7,015 in 2025
The $7,015 reported for 2025 was more than what 92% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.60 · 2022: $40.54 · 2023: $84.14 · 2024: $632 · 2025: $7,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,681 · Travel and Lodging: $1,662 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,681.27 |
| Travel and Lodging | $1,662.18 |
| Food and Beverage | $387.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,572.62 | 2024-2025 | |
| Davol INC. | $107.74 | 2019-2023 | Phasix Mesh |
| Kerecis Limited | $42.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Innovation Technologies INC | $40.54 | 2022 | |
| Haemonetics Corporation | $31.91 | 2025 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terral Goode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.